ABSA International
ABSA International

Resources with keywords: drug-resistant fungi



Tracking C. auris
CDC

C. auris is the first fungal pathogen designated an urgent antimicrobial resistance threat. 6,304 U.S. clinical cases in 2024; estimated ~7,000 in 2025. C. auris persists on surfaces and medical equipment for weeks; HCWs involved in wound care, catheter insertion, and line management are at highest risk of pathogen carriage and inadvertent transmission. Clinical mycology laboratory personnel should use BSL-2 precautions. Environmental sampling of patient rooms is recommended. Echinocandin-resistant strains increasing; consult infectious disease specialist for treatment.

Candida auris Containment Responses in Health Care Facilities that Provide Hemodialysis Services — New Jersey, North Carolina, South Carolina, and Tennessee, 2020–2023
CDC / MMWR
10 July 2025

Kurutz A, Innes GK, Sherman A, et al.
Candida auris, a frequently multidrug-resistant fungal pathogen, can spread within health care facilities. Dialysis facilities face particular infection prevention and control (IPC) challenges because their patients require complex medical care and frequent invasive procedures.

Risk Assessment tool for Fungi
ABSA EIDC
Candida auris: A drug-resistant fungus that spreads in healthcare facilities - A CDC message to laboratory staff
CDC
CDC Actions to Prevent the Spread of Antifungal Resistance
CDC
Drug-Resistant Candida auris
CDC
ZOHU Call: Sporotrichosis: overview and updates on an emerging zoonotic disease threat
CDC
1 March 2023

Cat-transmitted sporotrichosis has emerged as a zoonotic epidemic and major public health threat in Brazil with the potential of spreading to the United States

Go to Top